Long-term effectiveness of group-based diabetes self-management on glycosylated haemoglobin for people with type 2 diabetes in community: a protocol of systematic review and meta-analysis.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
    • Publication Information:
      Original Publication: [London] : BMJ Publishing Group Ltd, 2011-
    • Subject Terms:
      Diabetes Mellitus, Type 2*/therapy ; Self-Management*; Adult ; Blood Glucose ; Glycated Hemoglobin ; Humans ; Meta-Analysis as Topic ; Quality of Life ; Systematic Reviews as Topic
    • Abstract:
      Introduction: The rapid rise in the prevalence of diabetes has a negative impact on patients' quality of life. Diabetes self-management group education is cost-effective and efficient for patients to control blood glucose. However, there are no consistent standards for self-management group education, and its long-term effects (≥12 months) are unclear. Although a few systematic reviews evaluated the long-term effects, they did not make clear provisions on the content of self-management, and the number and sample size of included studies were small, which may lead to misclassification bias and reporting bias. Therefore, we plan to conduct this systematic review to evaluate the long-term effects of self-management group education and determine the effects of different self-management characteristics on glycosylated haemoglobin (HbA1c).
      Methods and Analysis: We will retrieve Chinese databases (Wanfang, Chinese Hospital Knowledge Warehouse) and English databases (PubMed, ScienceDirect, EMBASE, Web of Science, Bailian Platform, Cochrane Central Register of Controlled Trials, Google Scholar) for randomly controlled trials and cluster randomly controlled trials of which participants are adults with type 2 diabetes mellitus. We will manually search citation lists and trial registries, and consult authors to obtain relevant articles. The retrieval time range will be from the establishment of the database to July 2020 to avoid omitting relevant studies. The primary outcome will be HbA1c. The secondary outcomes will be fasting plasma glucose, postprandial blood glucose, total cholesterol, triglyceride, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, systolic blood pressure, diastolic blood pressure, body mass index, waist circumference and death event. Two reviewers will independently conduct article screening and assessment of risk of bias, with a third reviewer arbitrating if necessary. We will give priority to the use of meta-analysis to evaluate the pooled effects of all outcomes. For the outcomes of unrecognised sources of heterogeneity, missing data and less than three related studies, narrative synthesis approach will be used.
      Ethics and Dissemination: Ethical approval is not required for this systematic review. We plan to present the findings in a peer-reviewed scientific journal, relevant and responsible organisations, and training meetings.
      Prospero Registration Number: CRD42020209011.
      Competing Interests: Competing interests: None declared.
      (© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
    • References:
      BMJ. 2008 Apr 26;336(7650):924-6. (PMID: 18436948)
      Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003417. (PMID: 15846663)
      Diabetes Res Clin Pract. 2019 Nov;157:107843. (PMID: 31518657)
      BMC Health Serv Res. 2012 Jul 23;12:213. (PMID: 22824531)
      Diabetes Educ. 2009 Jul-Aug;35(4):641-51. (PMID: 19407333)
      J Clin Epidemiol. 2016 Dec;80:34-42. (PMID: 27531245)
      Lancet Diabetes Endocrinol. 2018 Feb;6(2):130-142. (PMID: 28970034)
      PLoS One. 2018 Jan 22;13(1):e0191262. (PMID: 29357380)
      Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Apr 6;54(4):406-410. (PMID: 32268648)
      Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Feb 6;53(2):206-211. (PMID: 30744298)
      Zhonghua Liu Xing Bing Xue Za Zhi. 2008 May;29(5):497-501. (PMID: 18956686)
      Diabet Med. 2017 Aug;34(8):1027-1039. (PMID: 28226200)
      Syst Rev. 2015 Jan 01;4:1. (PMID: 25554246)
      PLoS One. 2019 Aug 1;14(8):e0220116. (PMID: 31369582)
      Syst Rev. 2018 Jun 13;7(1):84. (PMID: 29898785)
      Patient Educ Couns. 2012 Jan;86(1):98-105. (PMID: 21592715)
      Diabetes Care. 2018 Jul;41(7):1414-1422. (PMID: 29703724)
      Diabetes Care. 2001 Mar;24(3):561-87. (PMID: 11289485)
      BMJ Open. 2018 Dec 14;8(12):e024262. (PMID: 30552277)
      BMJ Open. 2019 Jun 25;9(6):e025714. (PMID: 31243029)
      Diabetes Educ. 2009 May-Jun;35(3):439-54. (PMID: 19383882)
      Int J Surg. 2010;8(5):336-41. (PMID: 20171303)
    • Contributed Indexing:
      Keywords: diabetes & endocrinology; education & training (see medical education & training); medical education & training; protocols & guidelines
    • Accession Number:
      0 (Blood Glucose)
      0 (Glycated Hemoglobin A)
    • Publication Date:
      Date Created: 20210701 Date Completed: 20210803 Latest Revision: 20221207
    • Publication Date:
      20221213
    • Accession Number:
      PMC8246354
    • Accession Number:
      10.1136/bmjopen-2020-046692
    • Accession Number:
      34193493